Jeremy Franklin
- Pathology and Forensic Medicine top 0.2%
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Neurology top 1%
- Genetics top 1%
- Co-authors
- Volker DiehlAndreas EngertHans TeschDirk HasencleverAndreas JostingChristopher BaethgeMichael PfreundschuhMarkus Sieber
- Topics
- Lymphoma Diagnosis and Treatment (51 papers)Lung Cancer Treatments and Mutations (30 papers)Chronic Lymphocytic Leukemia Research (13 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Jeremy Franklin
144 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Pathology and Forensic Medicine 2.8k
- Oncology 1.6k
- Pulmonary and Respiratory Medicine 1.3k
- Neurology 1.2k
- Genetics 633
Countries citing papers authored by Jeremy Franklin
This map shows the geographic impact of Jeremy Franklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Franklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Franklin more than expected).
Fields of papers citing papers by Jeremy Franklin
This network shows the impact of papers produced by Jeremy Franklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Franklin. The network helps show where Jeremy Franklin may publish in the future.
Co-authorship network of co-authors of Jeremy Franklin
This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Franklin. A scholar is included among the top collaborators of Jeremy Franklin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Franklin. Jeremy Franklin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 27 | |
| 3 | 23 | |
| 4 | 10 | |
| 5 | 35 | |
| 6 | 12 | |
| 7 | 7 | |
| 8 | 69 | |
| 9 | 13 | |
| 10 | 29 | |
| 11 | 10 | |
| 12 | 129 | |
| 13 | 303 | |
| 14 | 9 | |
| 15 | 19 | |
| 16 | Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Diseasebreakdown → | 538 |
| 17 | Do children with Hodgkin's disease have a better prognosis than adults? Application of a generalised linear model to a systematic review of published results. | 0 |
| 18 | 55 | |
| 19 | 19 | |
| 20 | Spores in milk: problems associated with UHT processing. | 13 |
About Jeremy Franklin
Jeremy Franklin is a scholar working on Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine, having authored 147 papers that have together received 5.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (51 papers), Lung Cancer Treatments and Mutations (30 papers) and Chronic Lymphocytic Leukemia Research (13 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.8k citations), Neurology (1.2k citations) and Genetics (633 citations). Jeremy Franklin has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Volker Diehl, Andreas Engert, Hans Tesch, Dirk Hasenclever, Andreas Josting, Christopher Baethge, Michael Pfreundschuh, Markus Sieber, Hans–Konrad Müller–Hermelink and Bernd Dörken. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.